3M Settles PFAS-Related Claims with New Jersey for $285 Million, Resolving Legacy Chambers Works Litigation

Reuters
昨天
<a href="https://laohu8.com/S/MMM">3M</a> Settles PFAS-Related Claims with New Jersey for $285 Million, Resolving Legacy Chambers Works Litigation

3M Company has reached a significant agreement to settle all legacy claims related to the Chambers Works site in Salem County, New Jersey. The site, formerly owned by DuPont and now by The Chemours Company, has been at the center of litigation concerning PFAS contamination. The settlement, which is subject to court approval, involves a financial commitment from 3M, including a pre-tax present value of approximately $210 million to address the Chambers Works litigation and other settlement elements. Additionally, 3M has agreed to a pre-tax present value commitment of roughly $75 million to resolve current and future PFAS-related claims by the State of New Jersey, with payments commencing in 2030 and continuing through 2050. This resolution marks a crucial step for 3M in managing risk and uncertainty related to its historical operations and aligns with its strategic priorities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 3M Company published the original content used to generate this news brief via PR Newswire (Ref. ID: CG85963) on May 12, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10